Impact of adherence to antidepressants on long-term prescription opioid use cessation

Jeffrey F. Scherrer, Joanne Salas, Mark D. Sullivan, Brian K. Ahmedani, Laurel A. Copeland, Kathleen K. Bucholz, Thomas Burroughs, F. David Schneider, Patrick J. Lustman

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Background Depression contributes to persistent opioid analgesic use (OAU). Treating depression may increase opioid cessation. Aims To determine if adherence to antidepressant medications (ADMs) v. non-adherence was associated with opioid cessation in patients with a new depression episode after >90 days of OAU. Method Patients with non-cancer, non-HIV pain (n = 2821), with a new episode of depression following >90 days of OAU, were eligible if they received =1 ADM prescription from 2002 to 2012. ADM adherence was defined as >80% of days covered. Opioid cessation was defined as =182 days without a prescription refill. Confounding was controlled by inverse probability of treatment weighting. Results In weighted data, the incidence rate of opioid cessation was significantly (P = 0.007) greater in patients who adhered v. did not adhered to taking antidepressants (57.2/1000 v. 45.0/1000 person-years). ADM adherence was significantly associated with opioid cessation (odds ratio (OR) = 1.24, 95% CI 1.05-1.46). Conclusions ADM adherence, compared with non-adherence, is associated with opioid cessation in non-cancer pain. Opioid taper and cessation may be more successful when depression is treated to remission.

Original languageEnglish (US)
Pages (from-to)103-111
Number of pages9
JournalBritish Journal of Psychiatry
Volume212
Issue number2
DOIs
StatePublished - Feb 2018

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Impact of adherence to antidepressants on long-term prescription opioid use cessation'. Together they form a unique fingerprint.

Cite this